Home > Healthcare > Pharmaceuticals > Finished Drug Form > Acetaminophen Market

Acetaminophen Market Size

  • Report ID: GMI5935
  • Published Date: Jun 2023
  • Report Format: PDF

Acetaminophen Market Size

Acetaminophen Market size accounted for USD 9.8 billion in 2022 and is estimated to grow at a CAGR of 4.8% to reach USD 16.4 billion by 2032. The market is driven by the increasing use of paracetamol in conditions such as flu, fever, and headaches.

 

Acetaminophen is a commonly used painkiller for headaches and is available without prescription in most parts of the world. Hence, rising cases of infectious diseases and headache disorder is expected to positively influence the market growth. For instance, according to the Global Burden of Disease (GBD) study, headache disorders are among the most prevalent and disabling conditions worldwide. Similarly, as reported by the American Migraine Foundation, migraines affect 1 in 7 people globally. Additionally, acetaminophen when given intravenously acts as an effective treatment option in relieving pain and gives rapid relief.

 

Acetaminophen, also known as paracetamol, is a common painkiller widely used as an antipyretic and analgesic that relieves pain and reduces fever. Paracetamol is available combined with other painkillers and anti-sickness medicines. The drug is considered as over-the-counter drug and is available under a several brand names.

Authors: Mariam Faizullabhoy, Gauri Wani

Frequently Asked Questions (FAQ) :

Acetaminophen market size was USD 9.8 billion in 2022 and will record over 4.8% CAGR between 2023 to 2032.

The parenteral route of administration segment will reach around USD 1.3 billion by the end of 2032 as it offers direct and rapid delivery of the drug into the bloodstream.

North America holds the largest regional share in acetaminophen market due to the presence of key players, high incidence of fever, headaches, migraine, and a well-structured healthcare system.

BRISTOL-MYERS SQUIBB, Bayer AG, Sun Pharmaceutical Industries Limited, Glaxo SmithKline Pharmaceuticals Ltd, Alkem Laboratories Ltd, Abbott, B.BRAUN MELSUNGEN, Novartis AG, IOL Chemicals and Pharmaceuticals, Lupin Ltd, and Teva Pharmaceuticals USA, Inc.

Acetaminophen Market Scope

Buy Now


Premium Report Details

  • Base Year: 2022
  • Companies covered: 19
  • Tables & Figures: 268
  • Countries covered: 20
  • Pages: 180
 Download Free Sample